ACCUPANEL
DEAD

Serial Number

90858178

Owner

NGeneBio

Attorney

Andrew D. Bochner

Filing Date

Jul 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ACCUPANEL Trademark

Serial Number: 90858178

ACCUPANEL is a trademark filed by NGeneBio on July 30, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NGeneBio (2 trademarks)

Rooms 303-307, 904, Digital-ro 288
Guro-gu, Seoul 08390 , KR

Entity Type: 03

Trademark Details

Filing Date

July 30, 2021

Registration Date

Not Registered

Published for Opposition

June 14, 2022

Goods & Services

Laboratory devices for detecting genetic sequences; diagnostic kit for medical experiments comprising microcentrifuge tubes for medical research use

medical diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids, excluding medical diagnostic reagents and assays for use in blood glucose testing and diabetes care

diagnostic kit for medical experiments comprising reagents for medical research use

Medical testing for diagnostic or treatment purposes in the field of cancer

Medical diagnostic apparatus for testing DNA; Medical diagnostic apparatus for testing RNA; Medical diagnostic apparatus for testing cancer cells; Medical diagnostic apparatus for detecting cancer; Genetic testing apparatus for medical purposes; medical diagnostic test kit comprising tubes sold empty for collecting bodily fluids for genetic testing and detecting cancer; blood testing apparatus, excluding blood testing apparatus for use in blood glucose monitoring and diabetes care

Development and test of chemical production methods; biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; Biological research and analysis; biochemical research; Research and development of new products; Pharmaceutical drug development services; Pharmaceutical research services; pharmaceutical products evaluation; Providing laboratory research and medical laboratory services in the field of gene expression; Conducting clinical trials for others; chemical analysis; chemical research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 31, 2024 EX3G
SOU EXTENSION 3 FILED
May 31, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 6, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 6, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 6, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 6, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 6, 2022 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 23, 2022 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Aug 11, 2022 CHPB
ASSIGNED TO PETITION STAFF
Aug 9, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 26, 2022 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 14, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 9, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2022 CRFA
ASSIGNED TO LIE
May 5, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 2, 2022 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 2, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 2, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
May 2, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 2, 2022 CPEA
ASSIGNED TO EXAMINER
Apr 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2021 NWOS
NEW APPLICATION ENTERED
Aug 3, 2021 NWAP